About
Leonardo O. Reis, MD, MSc, PhD, MBA, Fulbright Physician-Scientist | Global Leader in Genitourinary Oncology | Builder of Translational Science Ecosystems With over 15 years of experience in urologic oncology, I have dedicated my career to advancing science that serves people. I am currently Professor Livre Docente at the State University of Campinas (UNICAMP), Brazil’s highest academic distinction, and Full Professor of Urology and Urologic Oncology at PUC-Campinas, São Paulo. I have founded and coordinate the Brazil’s National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT-UroGen), funded by the Ministries of Education and Health. I also founded the "Navis Mater" Immuno-Oncology Institute, a multidisciplinary platform hosted at PUC-Campinas, which serves as a hub for national collaboration and international translational science, closely integrated with the Comprehensive Center for Precision Oncology (C2PO) at the University of São Paulo, USP. 🔬 Scientist: Trained at leading institutions including Johns Hopkins, Columbia, and Harvard in the USA, also Fulbright Visiting Professor at Harvard University, I’ve authored 300+ PubMed-indexed publications, contributed to major textbooks, and served as associate editor for top peer-reviewed journals. My main research focus is oncoimmunology, biomarker discovery, and precision urology. 🧠 Mentor & Educator: I’m passionate about the teaching-learning process and have received multiple honors for my work in clinical care, research, and education. I proudly support the next generation of clinician-scientists through multicenter mentoring and collaborative capacity-building programs. 🌍 Strategic Leader & KOL: As a recognized Key Opinion Leader in oncology, I serve on scientific advisory boards, multidisciplinary expert panels, and funding review boards, bringing expertise in mode of action, mechanistic plausibility, and regulatory science. I’m deeply committed to evidence-based, balanced contributions to public health policy and innovation. 💡 Vision: Science embedded in health systems can transform lives. That’s why I work to connect people, platforms, and purpose, advancing global research partnerships, multisectoral fundraising, and health equity through innovation. 🚀 Let’s collaborate to build science beyond borders. #INCTUroGen #UroScience #FindTheOthers #InspireTheOthers Leonardo O. Reis MD MSc PhD MBA Fulbright - Professor of Urology and Uro-Oncology ("Livre Docente") - Founding Director - National Institute of Science Technology and Innovation in Genitourinary Cancer (INCT-UroGen) Campinas, São Paulo, Brazil. - Research Productivity 1 CNPq - UroScience / Urology / Oncology - Fulbrighter at MGB, Harvard, MA, USA http://br.linkedin.com/in/reisleouroscience/ http://lattes.cnpq.br/8285758239980543 https://orcid.org/0000-0003-2092-414X
Experience
Post-doctoral Fellow
Johns Hopkins University
Urology, Oncology, Uro-pathology
Post-doctoral Fellow
Columbia University
Translational Research https://www.scielo.br/j/acb/a/THcQc89JGwPcBvp4Hwm55cH/?lang=en
Fulbright Visiting Professor
Harvard University
Fulbrighter at Brigham and Women's Hospital and MGB, Harvard, MA, USA
Education
Pontifical Catholic University of Campinas (PUC-Campinas)
MD
State University of Campinas (Unicamp)
Surgery
State University of Campinas (Unicamp)
Urology / TiSBU
State University of Campinas (Unicamp)
MSc
State University of Campinas (Unicamp)
PhD
São Paulo State University (UNESP)
Livre-Docente Urologia
State University of Campinas (Unicamp)
Livre-Docente Urologia Oncológica
Pontifical Catholic University of Paraná (PUC-PR)
Master of Business Administration - MBA (AACSB accredited)
Skills
Publications
Document and citation trends
Publications Citations to them 1992 to 2027
Compiled from the open bibliographic record. These figures are counted from that record and are not the Top 2% ranking figures, so they will not match them.
Practical Management of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma.
PubMed , 2027
Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis
International Urology and Nephrology , 2026
Robot-assisted Radical Prostatectomy in the Brazilian Unified Health System (SUS): A Landmark in Surgical Public Health
International braz j urol , 2026
Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients
European Urology Oncology , 2026
Repositioning the Digital Rectal Examination in the Era of Risk-Adapted Prostate Cancer Diagnostics: Right Tool to the Right Patient at the Right Time
International braz j urol , 2026
Impact of intraoperative frozen section analysis (NeuroSAFE) on oncologic and functional outcomes after radical prostatectomy: A systematic review and meta-analysis.
Journal of Clinical Oncology , 2026
NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies
Journal of Robotic Surgery , 2026
From Surgical Innovation to Population Impact: Robot‐Assisted Radical Prostatectomy and the Evolution of Surgical Public Health in Brazil's Unified Health System
Chronic Diseases and Translational Medicine , 2026
Impact of parity and delivery type on pelvic floor muscle strength: a cross-sectional study in healthy continent women
BMC Urology , 2026
Micro-ultrasound compared with MRI-targeted biopsy in detecting clinically significant prostate cancer: Systematic review and meta-analysis.
Journal of Clinical Oncology , 2026
Other Publications
INCT UroGen and the Transformation of Brazilian Urologic Oncology: A Model for Trans-lational Science and Health Equity
International Brazilian Journal of Urology (IBJU), Nov 2025
https://www.intbrazjurol.com.br/pdf/vol51n06/IBJU20259914.pdf
Collaborator Notes
No notes yet.
Sign in to write a note.
Sign in to message, connect with or follow Leonardo O. Reis MD, MSc, PhD, MBA, Fulbright.
Sign in Create free account